To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Corticosteroid vs. Ozone Subacromial Injections for Rotator Cuff Tendinopathy

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2023

Corticosteroid vs. Ozone Subacromial Injections for Rotator Cuff Tendinopathy

Vol: 303| Issue: 2| Number:25| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison of ultrasound-guided subacromial corticosteroid and ozone (O(2)-O(3)) injections in the treatment of chronic rotator cuff tendinopathy: a randomized clinical trial

Korean J Pain. 2023 Jan 1; 36(1): 128–136.

Contributing Authors:
Mñ Atar N Korkmaz SG Aslan ñ Tezen SU K√∂yl√º Y Demir S Kesikburun

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Forty- four patients with rotator cuff tendinopathies were randomized to receive a single subacromial injection of corticosteroid (n=22) or three weekly subacromial injections of ozone (n=22). The primary outcome measure was the Western Ontario Rotator Cuff (WORC) score. Secondary outcome measures include the Shoulder Pain and Disability Index (SPADI) and pain on a Visual Analog Scale (VAS). Outco...

Join the Conversation

Please Login or Join to leave comments.